Literature DB >> 17115247

Treatment of bladder cancer in cardiac transplant patients.

Nadeem N Dhanani1, Ashish M Kamat.   

Abstract

We report a patient who presented with superficial bladder tumors 8 years after cardiac transplantation. He was managed conservatively with intra-vesical therapy for 5 years and ultimately underwent a successful radical cystoprostatectomy and urethrectomy 13 years after cardiac transplantation. This illustrates that cardiac transplant patients with superficial tumors may be managed with conservative therapies, but close vigilance is necessary to identify the opportune time for extirpative surgery.

Entities:  

Mesh:

Year:  2006        PMID: 17115247     DOI: 10.1007/s11255-005-4978-3

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  6 in total

1.  Superficial transitional cell carcinoma of the bladder associated with mucosal involvement of the prostatic urethra: results of treatment with intravesical bacillus Calmette-Guerin.

Authors:  R W Hillyard; L Ladaga; P F Schellhammer
Journal:  J Urol       Date:  1988-02       Impact factor: 7.450

2.  Invasive bladder cancer following cardiac transplantation.

Authors:  D D Baldwin; H C Ruckle
Journal:  Urology       Date:  1995-10       Impact factor: 2.649

3.  Radical cystectomy and lower urinary tract reconstruction after cardiac allograft transplantation.

Authors:  J P Stein; E C Skinner; J A Freeman; D Esrig; D G Skinner
Journal:  J Urol       Date:  1995-02       Impact factor: 7.450

4.  Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.

Authors:  D Esrig; J A Freeman; D A Elmajian; J P Stein; S C Chen; S Groshen; A Simoneau; E C Skinner; G Lieskovsky; S D Boyd; R J Cote; D G Skinner
Journal:  J Urol       Date:  1996-09       Impact factor: 7.450

5.  Urethral recurrence in patients following orthotopic urinary diversion.

Authors:  J Matthew Hassan; Michael S Cookson; Joseph A Smith; Sam S Chang
Journal:  J Urol       Date:  2004-10       Impact factor: 7.450

Review 6.  Post-transplant malignancy: the role of immunosuppression.

Authors:  I Penn
Journal:  Drug Saf       Date:  2000-08       Impact factor: 5.228

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.